Misoprostol for the Treatment of Postpartum Hemorrhage
Status:
Completed
Trial end date:
2008-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to test whether misoprostol is as effective as oxytocin for
treating primary postpartum hemorrhage (PPH) with uterine atony as the suspected cause in two
circumstances: 1) where women have received prophylactic uterotonics in the third stage of
labor; and 2) where no prophylactic uterotonics have been given in the third stage of labor.